Open AccessUrinary thrombin as a marker of local disseminated intravascular coagulation in patients with chronic kidney disease
Author(s) -
I. S. Mykhaloiko
Publication year - 2021
Publication title -
medičnì perspektivi
Language(s) - English
Resource type - Journals
eISSN - 2786-4804
pISSN - 2307-0404
DOI - 10.26641/2307-0404.2021.4.248157
Subject(s) - medicine , disseminated intravascular coagulation , kidney disease , nephrotic syndrome , gastroenterology , urine , renal function , thrombin , urinary system , nephritic syndrome , kidney , proteinuria , urology , pathology , platelet
The aim of this research was to study the diagnostic markers of nonovert local disseminated intravascular coagulation (DIC) syndrome in the urine of patients with chronic kidney disease (CKD). We conducted a prospective study involving 140 patients with CKD, of these patients, 100 patients (71.4%; 95% CI 53.4-76.7) had glomerulonephritis (GN) and 40 patients (28.6%; 95% CI 21.3-36.8) had diabetic nephropathy (DN). We diagnosed overt DIC syndrome on the International Society of Thrombosis and Haemostasis (ISTH) scale (>5 points) in 18.6 % of patients. We determined the level of thrombin in the urine of patients who had 1 ng/ml. The average level of thrombin in the urine of these patients was 6.5 (4.8; 10.6) ng/ml. In our opinion, the presence of thrombinuria indicates the intensity of monocytic-macrophage inflammation in the glomeruli and may be a criterion for nonovert, local DIC syndrome in the kidneys. The association of overt DIC syndrome with decreased blood albumin, reduced glomerular filtration rate (GFR), increased daily protein excretion (DPE) indicates its occurrence in severe underlying disease, in the presence of nephrotic syndrome and in the severe stages of CKD. Early diagnosis of nonovert local DIC syndrome would be more useful, since the process is still reversible and controlled, and timely use of antiplatelet and anticoagulant therapy would affect the course and the progression of CKD.